Federal health officials pronounced Monday they have combined new reserve warnings to a heart cadence drug Multaq, after a association investigate by Sanofi related a inscription to aloft rates of heart attack, cadence and genocide in a subset of patients.
News referensi http://news.yahoo.com/edarbyclor-approved-high-blood-pressure-044807118.html
No comments:
Post a Comment